NFKB1 and acute lymphoblastic leukemia: We have previously reported that the nitric oxide donating non-steroidal anti-inflammatory drug (NO-NSAID) para-NO-aspirin (para-NO-ASA) has anti-leukemic activity against human ALL by induction of apoptosis in association with suppression of NF-κB signalling [21].